![]() |
市場調查報告書
商品編碼
2026939
穿戴式心電圖監測儀市場預測至2034年-按類型、銷售管道、應用、最終用戶和地區分類的全球分析Wearable ECG Monitors Market Forecasts to 2034 - Global Analysis By Type (Wireless and Wired), Sales Channel (Pharmacy and Online), Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球穿戴式心電圖監測儀市場規模將達到 54 億美元,並在預測期內以 19.7% 的複合年成長率成長,到 2034 年將達到 231 億美元。
穿戴式心電圖監測儀是攜帶式設備,旨在持續追蹤和記錄心臟的電活動。它們以腕帶、貼片或衣物的形式出現,配備感測器,可即時監測心率並檢測心律不整和異常情況。這些設備能夠及早發現心律不整和心房顫動等心臟疾病,在預防性心臟健康管理中發揮至關重要的作用。
根據世界衛生組織(世衛組織)的數據,心血管疾病是全球首要死因,每年奪走約 1,790 萬人的生命。
心血管疾病盛行率增加
心血管疾病發生率的上升正在推動穿戴式心電圖監測儀市場的成長。隨著全球心臟相關疾病病例的增加,對持續心率監測的需求也日益成長。穿戴式心電圖監測儀能夠即時追蹤心率,從而實現對心律不整的早期發現和治療。此外,這些設備還有助於預防性健康監測,為使用者和醫療專業人員提供心臟健康的關鍵資訊。由於心血管疾病仍然是一個重要的健康問題,對穿戴式心電圖監測儀的需求不斷成長,使其成為有效監測和管理心臟疾病的重要工具。
對準確性和可靠性的擔憂
某些穿戴式心電圖 (ECG) 裝置可能難以持續提供準確可靠的測量結果,進而影響其臨床效用和診斷準確性。運動偽影、訊號雜訊以及電極與皮膚接觸狀況的變化等因素都會影響心電圖測量的準確性。依賴這些設備監測心臟健康或檢測心律不整的使用者可能會對所獲數據的可靠性產生不確定性。因此,醫護人員和使用者在臨床決策和醫學診斷中可能難以完全信任這些設備。
健康與健身的融合
將心電圖 (ECG) 監測功能整合到穿戴式健身設備中具有雙重優勢:不僅能為使用者提供健身追蹤功能,還能即時監測心臟健康狀況。透過在健身穿戴裝置中整合心電圖感測器,使用者可以在運動過程中評估心臟的電活動,並檢測可能預示潛在心臟問題的心律不整或心率變化。此外,這種整合也符合日益成長的健康意識消費者尋求全面健康監測解決方案的趨勢。將健康和健身監測功能結合在單一穿戴式裝置中,增強了市場吸引力,並滿足了更廣泛的消費者群體對整體健康管理的需求。
技術限制
技術限制,例如電池續航時間有限、連接問題和設備相容性問題,對實現最佳效能和使用者體驗構成挑戰。電池容量不足會限制穿戴式心電圖監測儀的運作時間,影響其連續監測功能。連接問題,包括無線連接不穩定以及與其他設備和平台的互通性問題,會阻礙資料的無縫傳輸和整合。設備相容性問題會限制高級功能的整合,並可能阻礙用戶採用。
新冠疫情的影響
新冠疫情對穿戴式心電圖監測儀市場產生了正面和負面的雙重影響。初期,為了減少面對面就診,人們對遠端醫療和遠端患者監護的關注度提高,加速了包括穿戴式心電圖設備在內的遠距監測解決方案的普及。然而,供應鏈中斷、醫療成本降低以及優先事項的轉變暫時減緩了市場成長。儘管面臨這些挑戰,疫情凸顯了遠端醫療監測的重要性,提高了人們對用於持續心電圖監測的穿戴式心電圖監測儀的長期需求,並促進了創新。隨著醫療系統在後疫情時代優先考慮遠距醫療解決方案,該市場有望進一步擴張。
在預測期內,無線領域預計將佔據最大佔有率。
無線領域預計將佔據最大的市場佔有率。無線穿戴式心電圖監測儀包括採用無線連接的設備,無需實體或有線連接。這些監測儀利用藍牙、Wi-Fi 或行動電話網路等無線技術,將即時心電圖數據傳輸到智慧型手機、平板電腦或指定的監控平台。此外,這種無線功能使用戶能夠擺脫線纜的束縛,自由移動,從而實現對心率活動的持續遠端監測。無線連線帶來的便利性和易用性正在推動這些穿戴式心電圖監測儀的普及,並滿足使用者在各種醫療和健身環境中尋求便利監測解決方案的需求。
在預測期內,醫院產業預計將呈現最高的複合年成長率。
預計在預測期內,醫院領域將迎來顯著成長。穿戴式心電圖監測儀正整合到醫院的工作流程中,用於在醫療機構內對患者進行持續的心率監測。這些監測儀能夠即時追蹤心率活動,幫助醫護人員密切監測住院患者的心臟健康狀況。此外,這些監測儀還使醫護人員能夠遠端存取和分析患者的心率數據,有助於早期發現異常情況、進行術後監測或持續監測心臟狀態。
在預測期內,亞太地區佔據了最大的市場佔有率,這主要得益於人口成長、醫療保健支出增加以及預防醫學意識的提高。該地區擁有巨大的成長潛力。中國、日本和印度等國家的快速技術進步正在推動創新,並促進穿戴式心電圖設備的普及。該地區不斷成長的老齡人口易患心臟病,這透過推動對持續心臟監測解決方案的需求,對市場產生了積極影響。此外,政府推行的數位化醫療措施以及遠端患者監護的日益普及,也促進了該地區市場的擴張。
北美地區預計將在整個預測期內保持盈利成長,這主要得益於其先進的醫療基礎設施、心血管疾病的高發生率以及精通技術的民眾。該地區對技術創新的高度重視以及數位醫療解決方案的日益普及,正在推動市場擴張。有利的報銷政策以及積極主動的健康管理舉措,正在促進穿戴式心電圖設備的普及。
According to Stratistics MRC, the Global Wearable ECG Monitors Market is accounted for $5.4 billion in 2026 and is expected to reach $23.1 billion by 2034 growing at a CAGR of 19.7% during the forecast period. Wearable ECG monitors are portable devices designed to track and record the heart's electrical activity continuously. They come in the form of wristbands, patches, or clothing equipped with sensors to monitor cardiac rhythms, detecting irregularities or abnormalities in real-time. These devices hold immense importance in proactive cardiac health management, enabling early detection of heart conditions such as arrhythmias or atrial fibrillation.
According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death in the world, killing about 17.9 million people each year.
Increasing prevalence of cardiovascular diseases
The increasing incidence of cardiovascular diseases fuels the wearable ECG monitor market. With rising cases of heart-related conditions globally, there's a growing need for continuous cardiac monitoring. Wearable ECG monitors offer real-time tracking of heart rhythms, enabling the early detection and management of cardiac irregularities. Moreover, these devices facilitate proactive health monitoring, providing users and healthcare professionals with vital insights into heart health. As cardiovascular diseases continue to pose a significant health concern, the demand for wearable ECG monitors rises, positioning them as crucial tools for monitoring and managing cardiac conditions effectively.
Accuracy and reliability concerns
Some wearable ECG devices encounter challenges in consistently delivering precise and reliable readings, impacting their clinical utility and diagnostic accuracy. Factors such as motion artefacts, signal noise, and variations in electrode contact with the skin can influence the accuracy of ECG measurements. Users relying on these devices for monitoring heart health or detecting irregularities might face uncertainty about the reliability of the obtained data. Consequently, healthcare professionals and users may exhibit hesitancy in fully trusting these devices for clinical decision-making or medical diagnoses.
Health and fitness integration
Integrating ECG monitoring capabilities into wearable fitness devices offers a dual benefit by providing users with not only fitness tracking features but also real-time monitoring of heart health. Incorporating ECG sensors into fitness wearables allows users to assess their heart's electrical activity during exercise, detecting irregularities or changes in heart rate that could indicate potential cardiac issues. Moreover, this integration aligns with the growing trend of health-conscious consumers seeking comprehensive health monitoring solutions. This convergence of health and fitness monitoring within a single wearable device enhances the market's appeal, catering to a broader consumer base concerned about holistic health tracking.
Technological limitations
Constraints in technological advancements, such as limitations in battery life, connectivity issues, or device compatibility, pose challenges in delivering optimal performance and user experience. Shortcomings in battery capacity restrict the operational duration of wearable ECG monitors, affecting continuous monitoring capabilities. Connectivity issues, including unstable wireless connections or interoperability problems with other devices or platforms, hinder seamless data transmission and integration. Also, device compatibility issues may limit the integration of advanced features or hinder user adoption.
Covid-19 Impact
The COVID-19 pandemic has both positively and negatively impacted the wearable ECG monitor market. Initially, it accelerated the adoption of remote monitoring solutions, including wearable ECG devices, due to an increased focus on telehealth and remote patient monitoring to minimise in-person visits. However, supply chain disruptions, reduced healthcare spending, and shifting priorities led to a temporary slowdown in market growth. Despite challenges, the pandemic highlighted the importance of remote healthcare monitoring, driving long-term interest in wearable ECG monitors for continuous cardiac monitoring, fostering innovation, and potentially expanding the market as healthcare systems prioritise remote care solutions in a post-pandemic environment.
The Wireless segment is expected to be the largest during the forecast period
The Wireless segment is estimated to hold the largest share. Wireless wearable ECG monitors encompass devices that employ wireless connectivity, eliminating the need for physical tethering or wired connections. These monitors use wireless technologies such as Bluetooth, WI-Fi, or cellular networks to transmit real-time cardiac data to smart phones, tablets, or designated monitoring platforms. Moreover, this wireless capability offers users freedom of movement without restrictive cables, allowing continuous and remote monitoring of heart activity. The convenience and ease of use offered by wireless connectivity enhance the adoption of these wearable ECG monitors, catering to users seeking hassle-free monitoring solutions in various healthcare and fitness settings.
The Hospitals segment is expected to have the highest CAGR during the forecast period
The Hospitals segment is anticipated to have lucrative growth during the forecast period. Wearable ECG monitors are integrated into hospital workflows for continuous cardiac monitoring of patients within medical facilities. They offer real-time tracking of heart activity, aiding healthcare professionals in closely monitoring patients' cardiac health during hospital stays. Moreover, these monitors enable healthcare providers to remotely access and analyse patients' heart data, facilitating early detection of irregularities, post-operative monitoring, or continuous surveillance of cardiac conditions.
Asia Pacific commanded the largest market share during the extrapolated period owing to its rising population, increasing healthcare expenditure, and increasing awareness regarding preventive healthcare, the region presents substantial growth potential. Rapid technological advancements, particularly in countries like China, Japan, and India, foster innovation and the adoption of wearable ECG devices. The market benefits from the region's expanding geriatric population prone to cardiac conditions, driving the demand for continuous cardiac monitoring solutions. Additionally, government initiatives promoting digital healthcare and the growing trend of remote patient monitoring contribute to the market's expansion in this region.
North America is expected to witness profitable growth over the projection period, owing to its advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and a tech-savvy population. The region's strong focus on technological innovations and increasing adoption of digital healthcare solutions propel market expansion. Favourable reimbursement policies, coupled with a proactive approach to health management, enhance the acceptance of wearable ECG devices.
Key players in the market
Some of the key players in the Wearable ECG Monitors Market include Medtronic, OMRON Corporation, Koninklijke Philips N.V, Dexcom, Inc, Masimo, Abbott, General Electric Company, VitalConnect, Bio-Beat, Preventice Solutions, Inc, VitalConnect, Contec Medical Systems Co Ltd., Fitbit, Inc, ten3T Healthcare, Huawei Technologies Co., Ltd and Apple.
In November 2023, Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral(TM) renal denervation (RDN) system, also known as the Symplicity(TM) blood pressure procedure, for the treatment of hypertension.
In August 2022, Medtronic, a global leader in healthcare technology, announced that it has entered into a strategic partnership with BioIntelliSense, a continuous health monitoring and clinical intelligence company, for the exclusive U.S. hospital and 30-day post-acute hospital to home distribution rights of the BioButton(R) multi-parameter wearable for continuous, connected monitoring.